Monday, November 4: PRE CONFERENCE DAY



Workshop 1: Tech Transfer Essentials

Are you new to tech transfer? This course will explain the foundations of tech transfer, the basics of intellectual property, licensing, negotiations, deal structures, evaluations, and marketing research.

Marie Kerbeshian, PhD, Assistant Vice President and Executive Director, University of Iowa Research Foundation
Ray Wheatley, MS, CLP(E), Director, Apio Innovation Transfer

Workshop 2: Tech Transfer Valuation Course

An in-depth look at how to value technology, especially as it applies to academic licensing. We will examine concepts such as valuation vs pricing and risk, valuation methodologies, including cost, industry standards, discounted cash flow and equity as well as payment structures. We will also go over real world case studies.


Andrew J. Maas, MS, JD, LL.M, RTTP, Associate Vice President for Research – Technology Transfer, Louisiana State University

Arundeep Pradhan, President, Apio Innovation Transfer (Apio-iX)




Workshops 1 & 2 Continued




Workshops 1 & 2 Continued




Workshops 1 & 2 Continued

Tuesday, November 5: CONFERENCE DAY 1


Breakfast and Networking



Yaron Daniely, PhD, CEO & President, Yissum;
Co-Chairperson, ITTN


Gil Granot, Chief Executive Officer, Yeda R&D;
Co-Chairperson, ITTN


Richard W. Chylla, PhD, CLP, RTTP, Chair of the Board at AUTM; Executive Director of MSU Technologies at Michigan State University




Infusion of Innovation and Entrepreneurship on Campus: Early Successes Create Significant New Goals

Prof. Yaffa Zilbershats, PhD, Head of Council for Higher Education





Expanding the University Knowledge Footprint

A Panel Discussion on Creative National and International TTO Initiatives


Moderator: Yaron Daniely, PhD, CEO & President, Yissum

Horacio Cartes, Former President of Paraguay, President of Grupo Cartes

Xiao Bin, General Manager, China- Israel (Shenzhen) International Innovation Center Co. Ltd

Netta Cohen, CEO, BGN Technologies

Ran Meged, Founder & CEO, Hopit

Prof Liu Qing, PhD, President, Jiangsu Industrial Technology Research Institute (JITRI)





  • TRACK A: Tech Transfer KPIs and Metrics: Old & New
    North American, Israeli & European organizations offer perspectives on changing models.

    : Ofra Weinberger, PhD
    , Director, Licensing & Commercialization, Columbia Technology Ventures; Assoc. VP, Technology
    Dr. Warner Brueckmann, Chief Technology Officer from the Geomar, Helmholtz Centre of Ocean Research
    Richard W. Chylla, PhD, CLP, RTTP, Chair of the Board at AUTM; Executive Director of MSU Technologies at Michigan State University
    Ariel Rabin, VP BD, Medical Devices & Digital Health, Hadasit
    Ivelina Metcheva, PhD, MBA, CLP, President, VCU Intellectual Property Foundation, Virginia Commonwealth University

  • TRACK B: Public-Private Collaborations – Can we Leverage the Best of Both Worlds?

    : Ronya Rubinstein, Adv.
    , Director, R&D Unit, Rambam Health Care Campus

    Sharon Bar-Ziv, PhD, Lecturer, Sapir Academic College, School of Law

    Efrat Hexter, Manager, Medical Imaging Analytics Group, IBM Research

    Prof. Rivka Carmi, Ben Gurion University
    Karin Mayer Rubinstein, CEO & President, Israel Advanced Technology Industries (IATI)

  • TRACK C: Best Practices in Establishing University-Based Innovation and Entrepreneurship Centers
    Key considerations and recommended initiatives to adopt – or avoid; leaders of academic innovation and entrepreneurship centers share experiences

    : Amnon Dekel, PhD
    , Executive, Director, HUJI Innovate
    Dana Gavish-Fridman, VP of Entrepreneurship, BGN Technologies; Head of Entrepreneurship, Ben Gurion University
    Yair Sakov, Managing Director, Innovation and Entrepreneurship Center, Tel Aviv University
    Prof. Ezri Tarazi, Chair of t-Hub, Innovation and Entrepreneurship Center, Technion-Israel Institute of Technology
    Alon Barnea, VP Development, Afeka Tel-Aviv Academic College of Engineering & CEO, Afeka Yissumim Ltd



An Optimal Tech Transfer Business Model: How Selecting between a Tech Transfer Organization (TTO), Tech Transfer Company (TTC) or other Relevant Models Impacts Tech Transfer KPIs.
A moderated lively debate exploring the advantages and disadvantages of a university-based knowledge and technology transfer organization. 

Moderator: Tony Raven, CEO of Cambridge Enterprise

Gil Granot, Chief Executive Officer, Yeda R&D

Hanoch Gutfreund, Former President, The Hebrew University of Jerusalem

Dr. Lim Jui, Head, NTU Singapore

Prof. David Mirelman, PhD, Department of Biomolecular Sciences,​Weizmann Institute of Science





  • Roundtable I: Developing a TTO Career Including Advancement & Compensation

    Moderator: Andrew J. Maas, Associate Vice President for Research – Technology Transfer, Louisiana State University
    Linara Axanova, Associate Director at University of Pennsylvania, Penn Center for Innovation
    Dganit Yaari, CPA (IL), CFO, BGN Technologies Ltd


  • Roundtable II: Key Challenges and Opportunities in Increasing Faculty Involvement in University Spin-Out Creation

    : Gideon Ben-Zvi
    , Angel Investor & Venture Capitalist

    Dr. Lim Jui, Head, NTU Singapore
    David Schottenfels, Adv, Partner, Salomon, Lipschutz’ Hi-Tech Department
    Prof. Yigal Erel, PhD, Institute of Earth Sciences, Hebrew University of Jerusalem



Brainstorming New Models for Inter-Institutional and International Knowledge-based Collaborations 

An interactive, engaging session designed to present multi-disciplinary groups with “teasers” for creating novel frameworks for inter-institutional and cross-border collaborations based on knowledge transfer, open innovation and technology commercialization.

Wednesday, November 6: CONFERENCE DAY 2


Breakfast and Networking


The Innovation Synergy between Israel and China
Cui Yuting, PhD, Science & Technology Counsellor, Embassy of the People’s Republic of China in the State of Israel


Opening Plenary

Top International TTOs Share Historical Perspectives, War Stories & Future Predictions
TOP TTOs from Asia, Europe and Israel share their experiences

Moderator: Keren Primor Cohen, LL.B, LL.M, CEO, Ramot at Tel Aviv University Ltd

Irit Gal, Senior Licensing Associate, Stanford University

Ofra Weinberger, PhD, Director, Licensing & Commercialization, Columbia Technology Ventures; Assoc. VP, Technology

Tony Raven, CEO, Cambridge Enterprise

Gil Granot, Chief Executive Officer, Yeda R&D





Innovation & Collaboration
  • Panel A: From Push to Pull: TTOs New Tools for Ideation and Portfolio Diversification

    Moderator: Roee Atlas, PhD, CEO Rambam MedTech Ltd., Technology Transfer, Rambam Hospital

    Aykut Gulalanlar, CLP, RTTP, PMP, Senior Partner, TLS.IP |Technology |Licensing | Strategy

    Nancy Sullivan, CEO and Managing Director, IllinoisVENTURES, LLC

    Aviv Zeevi Balasiano, PhD, VP, Head of Division, Technological Infrastructure Israel Innovation Authority

  • Panel B: Fostering A Strong Collaboration between China & Israel: Turning Interest into Action

    : Prof. Dongmin Chen
    , Dean/Prof, School of Innovation & Entrepreneurship, Peking University
    Amir Gal Or, Founder & Managing Partner, Infinity Group the leading Israeli-Chinese Equity Fund
    Prof. Shlomo Noy, MD, PhD, The former Director-General of the Sheba Medical Center; General Partner of The Guangzhou-Israel Sino Bioindustry Investment Fund (GIBF)
    Dr. Itamar Borowitz, Chairman, Yissum Research & Development Company of the Hebrew University
    Daniel Green, Partner, Yigal Arnon & Co., Senior Member of Technology Transactional Group & Co-Head of China Practice
    Rona Samler, CBO, Technion R&D Foundation Ltd.; Managing Director, T3; CEO, AMIT Venture



Success Stories as Told From Different Angles: The Entrepreneur, The Academic; The Investor, The Government

Moderator: Dov Moran, Managing Partner of Grove Ventures

Aviv Bakal, CEO and Co-Founder, TriEye

Prof. Uriel Levy, CTO, TriEye; Director of the Nanocenter, The Hebrew University of Jerusalem





  • Roundtable I: New World Order: How Global Trade Wars are Influencing China’s Tech Transfer:  Global Status Trends & Challenges

    David Ai, JD, MS, MBA
    , Chief Innovation Officer & Director of Innovation & Commercialization, University of Hawaii System

    Amir Lati, Director of North East Asia Department, Israel Ministry of Foreign Affairs

    Prof. Dongmin Chen, Dean/Prof, School of Innovation & Entrepreneurship, Peking University

    Richard W. Chylla, PhD, CLP, RTTP, Chair of the Board at AUTM; Executive Director of MSU Technologies at Michigan State University

    Julia Zhen, PhD, CLP, Director, Innovation Partnerships, Thermo Fisher Scientific


  • Roundtable II: University Seed Venture Funds – How to Use Them Wisely

    Nancy Sullivan
    , CEO and Managing Director, IllinoisVENTURES, LLC
    Lior Buchman, CFO, Integra Holdings

    Elka Nir, CEO, Carmel ltd. & Carmel Innovations fund
    Keren Primor Cohen, LL.B, LL.M, CEO, Ramot at Tel Aviv University Ltd
    Nadav Klein, Principal, Triventures


  • Roundtable III: TTO Contract and Patent Enforcement and Patent Monetization

    Yael Baratz, LL.B
    , Senior Partner & Chair of the Corporate & Licensing Group, Pearl Cohen Zedek Latzer Baratz

    Yoav Navon, Director of Litigation Finance, Woodsford Litigation Funding

    Bob Trachtenberg, General Counsel, Yissum Research Development Company of Jerusalem

    Marcella Eytan, LL.B, Partner, Pearl Cohen Zedek Latzer Baratz

    Yoav Alkalay, LL.B, LL.M, Partner, Pearl Cohen Zedek Latzer Baratz

    Alan Minsk, JD, Partner, Head of Food & Drug Team, Arnall Golden Gregory LLP





Winning The Lottery: Revenue vs. Broader Social Impact and the Role of Licensing Today
Traditional TTOs discuss these ideas with major firms that routinely license technologies.


Moderator: Irit Gal, Senior Licensing Associate, Stanford University

Larry Loev, CEO, Ariel Scientific Innovations, Ltd
Lukas Madl, RTTP, Registered Technology Transfer Professional, tecnet equity NÖ Technologiebeteiligungs-Invest GmbH
Yaron Daniely, PhD, CEO & President, Yissum 
Marc Feiglin, Head of Global Alliance Management & Partnerships, Merck Group


A Night of Foodtech, Science and Innovation in Jerusalem’s Most Famous Outdoor Market

The best of food tech innovation will be on display while you enjoy dinner, drinks and music in this legendary market bursting with creative energy.

  • Beer Bazaar, ביר בזר, Etz Hayim 3

19:30-19:45:Mycelium-Based Alternative Protein: Sustainable, Tasty and Inexpensive,
Dr. Daria Feldman, Co-Founder and CTO of Kinoko-Tech


19:45-20:00: The Making of a Smart Food Supplement: Bridging Nature and Science for the Consumer 
Prof Ruth Gabizon, Hadassah Medical Center and Co-Founder of Granalix

20:00-20:15: ChickP – The Best Plant Protein in the Market
Ron Klein, CEO, Chick P

  • Full House, פול האוס, Hashezif 14

19:30-19:45: A Pint from the Past: Re-creation of Ancient Beer Using Yeast from Archaeological Vessels
Dr. Ronen Hazan, The Hebrew University of Jerusalem

19:45-20:00 Better-Juice, Naturally Reducing Sugar from 100% Fruit Juices
Dr. Eran Blachinsky, CEO Better Juice

  • Casino de Paris, קזינו דה פריז,  Machane Yehuda 3

19:30-19:45:  We Print to Drive
Stefanie Brickwede, Head of AM Deutsche Bahn

19:45-20:00: Berlin’s Path to the Capital of Additive Manufacturing
Sybille Weimann, Berlin Partner, Business Promotion

20:00-20:15:  3D and 4D Printing: The Next Industrial Revolution
Prof. Shlomo Magdassi, The Hebrew University of Jerusalem


Thursday, November 7: CONFERENCE DAY 3


Breakfast and Networking


Opening Plenary

Turning Tables – What Investors and Corporations Expect from TTOs
Top investors and industry executives offer insight on how to pitch your technologies to get their attention

Moderator: Tamar Raz, PhD, CEO, Hadasit Medical Research Services and Development Ltd.

Marius Nacht, Anchor Investor & Co-Founder, aMoon Fund; Chairman of Check Point Software Technologies

Regine Shevach, Managing Director at Inter-Lab, an affiliate of Merck KGaA

Jonathan Berger, CEO, The Kitchen Hub by Strauss





Deal Flow and Investment Opportunities

Representatives from industry verticals share industry wide needs and trends, and present their companies’ technological needs in search of new commercialization opportunities

11:00-11:25 FutuRx
Ido Kaminsky, Business Analysis Director
FutuRx was founded by three leading global healthcare players – Takeda (Takeda Ventures Inc.), Johnson & Johnson (JJDC), and OrbiMed Israel Partners. By combining the expertise of its management and the capabilities of its founders, FutuRx provides a unique model for the transformation of breakthrough discoveries into novel medicines.

11:25-11:35  Israel Chemicals (ICL) Group
Ziv Kohav, Business Development
ICL is one of the world’s leading fertilizer and specialty chemicals companies. ICL is interested in early stage technologies of Crop Nutrition, Flame Retardants, Additives for Paints and Coatings, Industrial Biocides and applications utilizing Bromine. We provide research funds for further development of relevant technologies and we partner with the innovators to guide the funded projects towards success and licensing by ICL.

11:35-11:45 aMoon
Roy Wiesner, Managing Director
aMoon is the largest healthtech and life sciences venture fund in Israel, focused on accelerating cures for the world’s most life-threatening conditions and on technologies providing solutions for global healthcare’s biggest cost drivers.

11:45-11:55 Labs O2
Stav Erez, Partner & EVP Business Development
Labs/02 is Jerusalem’s seed-stage incubator, backed by OurCrowd, Reliance Industries and Motorola Solutions and in partnership with the Hebrew University of Jerusalem. Labs/02’s core mission is to advance cutting-edge technology that will shape the future. One of Labs/02’s unique skills is engaging in venture creation, taking high level academic work and transforming it into revolutionary startups.

11:45-11:55 VLX
Moran Ben David Shapira, Chief Business Development
We invest in early-stage startups led by exceptional entrepreneurs. Our sweet spots are data driven, biotechnology and pharma companies, as well as digital pharma, utilizing notions from two or more of these domains. Our seed investments ($700K-$1M) are performed via our technological incubator in Jerusalem. We do follow-on investments.

Hagit Binder, VP Projects and Marketing
Chem-pharma solutions – Turning Biomed Innovation into Pharmaceutical Products




The Ecosystem Tour is a special event for AUTM Asia participants that will take you to the heart of Israel’s Innovation in the center of Tel Aviv. We will stop for a traditional Israeli lunch followed by a visit to The Center for Israeli Innovation. We will continue with a tour down the most successful entrepreneurial street in modern history and home to Israel’s financial center, the iconic Rothschild Blvd.

Finally, we will visit Moveo, a tech and creative agency working with domestic and international leading startups and brands. During the tour in Moveo’s offices, you will get a glimpse into the company’s unique story, starting from its days as a startup all the way to nowadays, as a vibrant successful company growing at an annual rate of over 100% for over 4 years.

About The Center for Israeli Innovation: The center provides a unique interactive experience, offering a glimpse into one of the most renowned topics– the Israeli startup ecosystem. 

With more than 55,000 visitors a year, the center shares the story of the Startup-Nation. Hundreds of international business delegations, as well government, academic & philanthropic delegations, all come to explore the groundbreaking technologies and the people behind them.

In our exhibition, you will find over 80 leading Israeli technology companies– (NICE, RAFAEL, ELBIT, IAI, CHECK POINT and ORBOTECH).

About Moveo: Moveo is a tech and creative agency, providing cutting edge solutions for startups and brands. Our range of services includes Mobile and Web Development, AR/VR, UX/UI Design, Branding, and Marketing. Moveo began as a startup itself, making it fully aware of the challenges of companies trying to reach their next milestone and pave their way towards success. With more than 70 team members, Moveo’s services are characterized by constant availability, commitment, dedication, and flexibility.

Close Menu